HomeCompareSKWG vs MRK

SKWG vs MRK: Dividend Comparison 2026

SKWG yields 136.05% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SKWG wins by $15.34M in total portfolio value
10 years
SKWG
SKWG
● Live price
136.05%
Share price
$1.47
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15.39M
Annual income
$6,293,323.05
Full SKWG calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SKWG vs MRK

📍 SKWG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSKWGMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SKWG + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SKWG pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SKWG
Annual income on $10K today (after 15% tax)
$11,564.63/yr
After 10yr DRIP, annual income (after tax)
$5,349,324.59/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SKWG beats the other by $5,340,996.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SKWG + MRK for your $10,000?

SKWG: 50%MRK: 50%
100% MRK50/50100% SKWG
Portfolio after 10yr
$7.72M
Annual income
$3,151,560.60/yr
Blended yield
40.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SKWG
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SKWG buys
0
MRK buys
0
No recent congressional trades found for SKWG or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSKWGMRK
Forward yield136.05%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$15.39M$56.8K
Annual income after 10y$6,293,323.05$9,798.13
Total dividends collected$14.14M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SKWG vs MRK ($10,000, DRIP)

YearSKWG PortfolioSKWG Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$24,305$13,605.44$11,206$366.19+$13.1KSKWG
2$56,912$30,905.26$12,650$502.35+$44.3KSKWG
3$128,528$67,631.59$14,407$694.19+$114.1KSKWG
4$280,268$142,743.86$16,585$967.82+$263.7KSKWG
5$590,792$290,905.24$19,342$1,363.89+$571.5KSKWG
6$1,205,245$573,097.64$22,913$1,947.19+$1.18MSKWG
7$2,382,274$1,092,661.12$27,662$2,823.89+$2.35MSKWG
8$4,567,482$2,018,449.47$34,159$4,173.35+$4.53MSKWG
9$8,503,963$3,616,756.90$43,337$6,308.80+$8.46MSKWG
10$15,392,564$6,293,323.05$56,776$9,798.13+$15.34MSKWG

SKWG vs MRK: Complete Analysis 2026

SKWGStock

Humanatare Distribution Corp finances and distributes life-saving healthcare products. It offers products to eradicate various diseases, such as Tuberculosis in the developing world. Humanatare Distribution Corp was formerly known as TIE Technologies, Inc. and changed its name to Humanatare Distribution Corp in July 2012. The company was incorporated in 1980 and is based in Charlotte, North Carolina.

Full SKWG Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SKWG vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SKWG vs SCHDSKWG vs JEPISKWG vs OSKWG vs KOSKWG vs MAINSKWG vs JNJSKWG vs ABBVSKWG vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.